beta-hydroxyisovaleric acid has been researched along with Wasting Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holeček, M | 1 |
| Mukerji, P; Smith, HJ; Tisdale, MJ | 1 |
| Palisin, T; Stacy, JJ | 1 |
2 review(s) available for beta-hydroxyisovaleric acid and Wasting Disease
| Article | Year |
|---|---|
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
Topics: Animals; Cachexia; Dietary Supplements; Health; Humans; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates; Wasting Syndrome | 2017 |
Beta-hydroxy-beta-Methylbutyrate and its use in athletics.
Topics: Adult; Aged; Aged, 80 and over; Dietary Supplements; Dose-Response Relationship, Drug; Drug Interactions; Exercise; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Sports; Valerates; Wasting Syndrome; Weight Lifting | 2005 |
1 other study(ies) available for beta-hydroxyisovaleric acid and Wasting Disease
| Article | Year |
|---|---|
Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Topics: Animals; Body Weight; Eicosapentaenoic Acid; Humans; Kinetics; Mice; Muscle, Skeletal; Neoplasm Proteins; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Valerates; Wasting Syndrome; Weight Loss | 2005 |